Sign In
Buy ORMP
$4.07
-0.0500 (-1.21%)
At Close: Jul 31, 2026
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine
10:30am, Tuesday, 10'th Aug 2021
BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on
Oramed to Present at Canaccord Genuity's 41st Annual Growth Conference
08:40am, Monday, 09'th Aug 2021
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug deliver
Oramed Will Soon Start Clinical Trials For Oral COVID-19 Vaccine In Israel, Out licensed Injectable Version To Premas Biotech In India
11:44am, Wednesday, 21'st Jul 2021
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) announced several updates for its majority-owned company Oravax Medical Inc. Oravax is gearing up to commence clinical trials for its oral COVID-19 vaccine,
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
08:40am, Tuesday, 22'nd Jun 2021
NEW YORK, June 22, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug deliv
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine
08:40am, Tuesday, 25'th May 2021
NEW YORK, May 25, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delive
Oramed Pharmaceuticals: Interesting Late-Stage Oral Insulin Developer
06:09pm, Sunday, 23'rd May 2021
Oramed Pharmaceuticals is developing an oral insulin in late clinical stages. Trial data has been positive, and the market potential is huge.
NEW YORK, April 21, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug deli
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA's Approved Dual Concurrent Protocol
08:51am, Tuesday, 23'rd Mar 2021
NEW YORK, March 23, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug de
ORMP Stock Price Increased Over 40% Pre-Market: Why It Happened
05:09am, Tuesday, 23'rd Mar 2021
The stock price of Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) increased by over 40% pre-market. This is why it happened.
Oramed Shares Gain On COVID-19 Vaccine Joint Venture Pact
09:34am, Friday, 19'th Mar 2021
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) has entered into definitive agreements to form a joint venture focused on developing oral COVID-19 vaccines. The new company, Oravax Medical Inc, will use
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines
08:40am, Friday, 19'th Mar 2021
NEW YORK, March 19, 2021 /PRNewswire/ -- Good candidate for protection against COVID variants due to triple antigen targeting Implications for potential ease of widescale distribution and administra
Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study
08:25am, Thursday, 21'st Jan 2021
NEW YORK, Jan. 21, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delive
Oramed to Present at H.C. Wainwright BioConnect 2021 Conference
08:40am, Thursday, 07'th Jan 2021
NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug deliver
Oramed Reports Positive First in Human Data from Oral Leptin Study
08:25am, Wednesday, 23'rd Dec 2020
NEW YORK, Dec. 23, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delive
Oramed Initiates Phase 2 NASH Trial of Oral Insulin
08:25am, Wednesday, 02'nd Dec 2020
NEW YORK, Dec. 2, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug deliver
